Evaluation of the iodoacetic acid effects on adipose-derived mesenchymal stem cells and alteration of their osteogenic differentiation potential by inducing oxidative stress.
{"title":"Evaluation of the iodoacetic acid effects on adipose-derived mesenchymal stem cells and alteration of their osteogenic differentiation potential by inducing oxidative stress.","authors":"Nastaran Ansari Noghlebari, Atieh Hajarizadeh, Niloofar MohammadEbrahim, Malathi H, Vikrant Abbot, Atreyi Pramanik, Elaheh Esmaeili","doi":"10.1007/s00210-025-03870-0","DOIUrl":null,"url":null,"abstract":"<p><p>Drinking water disinfection byproducts (DBPs) can adversely affect human health. Iodoacetic acid (IAA) is a DBP associated with most cytotoxic, genotoxic, and mutagenic disorders. However, its effects on the osteogenic differentiation of adipose-derived mesenchymal stem cells, ADMSCs, remain unknown. In this study, the cytotoxicity, cytokine response, phenotype, and osteogenic differentiation potential of the ADMSCs were evaluated in the presence and absence of IAA. It was revealed that IAA induces a toxic response at a concentration of 2 µM. Flow cytometry confirmed no significant alterations in ADMSCs' phenotype after treatment with 10 nM and 1 µM IAA for 48 h. IAA led to a decreased secretion of IL-8, a dose-dependent secretion of IL-10, and no significant change in the secretion of IL-6 compared to the control group. The osteogenic differentiation ability of ADMSCs in the presence of different concentrations and exposure times to IAA was evaluated by measurement of alkaline phosphatase activity, calcium content, Alizarin Red S, real-time PCR, and immunocytochemistry assays. The findings show that the osteogenic differentiation of ADMSCs decreased at higher concentrations of IAA and extended exposure time, confirming the potential disruption of the osteogenic differentiation of ADMSCs.</p>","PeriodicalId":18876,"journal":{"name":"Naunyn-Schmiedeberg's archives of pharmacology","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Naunyn-Schmiedeberg's archives of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00210-025-03870-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Drinking water disinfection byproducts (DBPs) can adversely affect human health. Iodoacetic acid (IAA) is a DBP associated with most cytotoxic, genotoxic, and mutagenic disorders. However, its effects on the osteogenic differentiation of adipose-derived mesenchymal stem cells, ADMSCs, remain unknown. In this study, the cytotoxicity, cytokine response, phenotype, and osteogenic differentiation potential of the ADMSCs were evaluated in the presence and absence of IAA. It was revealed that IAA induces a toxic response at a concentration of 2 µM. Flow cytometry confirmed no significant alterations in ADMSCs' phenotype after treatment with 10 nM and 1 µM IAA for 48 h. IAA led to a decreased secretion of IL-8, a dose-dependent secretion of IL-10, and no significant change in the secretion of IL-6 compared to the control group. The osteogenic differentiation ability of ADMSCs in the presence of different concentrations and exposure times to IAA was evaluated by measurement of alkaline phosphatase activity, calcium content, Alizarin Red S, real-time PCR, and immunocytochemistry assays. The findings show that the osteogenic differentiation of ADMSCs decreased at higher concentrations of IAA and extended exposure time, confirming the potential disruption of the osteogenic differentiation of ADMSCs.
期刊介绍:
Naunyn-Schmiedeberg''s Archives of Pharmacology was founded in 1873 by B. Naunyn, O. Schmiedeberg and E. Klebs as Archiv für experimentelle Pathologie und Pharmakologie, is the offical journal of the German Society of Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, DGPT) and the Sphingolipid Club. The journal publishes invited reviews, original articles, short communications and meeting reports and appears monthly. Naunyn-Schmiedeberg''s Archives of Pharmacology welcomes manuscripts for consideration of publication that report new and significant information on drug action and toxicity of chemical compounds. Thus, its scope covers all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Moreover, submission of clinical trials with healthy volunteers or patients is encouraged. Short communications provide a means for rapid publication of significant findings of current interest that represent a conceptual advance in the field.